Incyte Corp (INCY)

With August now upon us, not only is the overbought market vulnerable to profit-taking, the calendar is working against stocks as well. One average, the market loses ground rather than gains ground in the month of August, as well as for September.

4 Biotech Stocks Sliding Lower

By William Roth, InvestorPlace Market Strategist Jul 26, 2019

Biotech stocks have been looking rough lately, and these four names have been helping to lead the charge lower.

Nasdaq Today: Semis Rally, Micron Earnings, Suing FB and GOOGL?

By Bret Kenwell, InvestorPlace Contributor Jun 26, 2019

Trump says that Facebook and Alphabet should be sued, while Micron surged on earnings. Semiconductors got a big boost in the Nasdaq today as well.

Nasdaq Today: Maintaining Altitude Amid Uncertainty

By Bret Kenwell, InvestorPlace Contributor Jun 21, 2019

PayPal, Slack, and chip stocks like AMD and Nvidia, Micron and Nio were all big movers in the Nasdaq today. Get the scoop, now.

7 Hot Stocks to Buy for a Seemingly Sleepy Summer

By James Brumley, InvestorPlace Feature Writer Jun 18, 2019

Incyte, Whirlpool and Baxter are just some of the hot stocks to buy here as a means of shrugging off the summer's looming lethargy.

7 Top-Rated Biotech Stocks to Invest In Today

By Louis Navellier, Editor, Growth Investor Jun 14, 2019

Despite the trade dispute with China, these biotech stocks each earn top marks in Portfolio Grader for fundamentals, earnings and momentum.

5 Biotech Stocks for a Long-Lived Portfolio

By Chris Lau, InvestorPlace Contributor Apr 30, 2019

Biotech stocks fell sharply in the last few weeks, mostly on no new news. This drop may have created an entry point for investors.

3 Big Stock Charts for Wednesday: Incyte, FMC and LyondellBasell

By James Brumley, InvestorPlace Feature Writer Apr 10, 2019

The stock charts of INCY, LYB and FMC are going to start this week's hump-day at a precipice. Here are the numbers to know.

3 Big Stock Charts for Wednesday: Cabot Oil & Gas, Incyte and Sempra Energy

By James Brumley, InvestorPlace Feature Writer Feb 27, 2019

The stock charts of COG, INCY and SRE are worth a closer technical look at the midpoint of the trading week.

3 Big Stock Charts for Monday: Pfizer, MGM Resorts and Incyte

By James Brumley, InvestorPlace Feature Writer Jan 28, 2019

The stock charts of PFE, INCY and MGM are finally making good on previously-suggested promise.

3 Big Stock Charts for Friday: Incyte, Schlumberger and Abbott Laboratories

By James Brumley, InvestorPlace Feature Writer Jan 4, 2019

The stock charts of INCY, ABT and SLB are set to end the week on a more definitive, trade-worthy footing than most other names.

3 Big Stock Charts for Monday: Entergy, Incyte and SL Green Realty

By James Brumley, InvestorPlace Feature Writer Aug 6, 2018

The stock charts of SLG, INCY and ETR are shaping up as the best trading bets as the new week kicks off.

Incyte Corporation Stock Plunges on Melanoma Drug Trial Failure

By William White, InvestorPlace Writer Apr 6, 2018

Incyte (INCY) was falling hard on Friday following news of a failed Phase 3 drug trial for its melanoma drug epacadostat.

10 Deceptively Bad Stocks to Sell Before You’re Pranked

By Louis Navellier, Editor, Growth Investor Mar 30, 2018

If you’re itching to buy, avoid these stocks at all costs. Here's what makes them stocks to sell for all wise investors.

10 Secret Stocks Top Investors Are Betting On

By Harriet Lefton, Writer, TipRanks Feb 1, 2018

Here are the 10 stock picks top investors are betting on right now. We take a look at how investors are trading these stocks -- and whether the Street agrees.

5 Big Biotech Stocks To Buy In 2018

By Aaron Levitt, InvestorPlace Contributor Jan 17, 2018

Biotech stocks had a great run in 2017. The new year could have more big gains ahead. Here are 5 top biotech stocks to buy today.

5 Stocks the Top Fund Managers Love

By Harriet Lefton, Writer, TipRanks Nov 20, 2017

These top hedge fund stocks all have a 'very positive' confidence sentiment for the quarter and a 'Strong Buy' outlook from the Street.

Vapid Earnings Visibility Restrict Incyte (INCY) Rating

By Portfolio Grader Nov 6, 2017

Incyte Corp (NASDAQ:INCY) is a $22.2 billion in market value member of the Biotechnology GICS industry group where Portfolio Grader's current ranking for INCY puts it 171 among the 349 companies in this industry group, placing it in the top half. INCY is ranked in the third quartile of the sector with a ranking of 402 among the 785 companies in the sector and number 2,601 in the 5000 company Portfolio Grader company universe.